Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIDH.L Regulatory News (IDH)

  • There is currently no data for IDH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notifiable Interest

20 Mar 2007 17:33

Immunodiagnostic Systems Hldgs PLC20 March 2007 Immunodiagnostic Systems Holdings PLC ("the Company") Notifiable Interest A form TR-1 containing the following information has been received by theCompany. TR-1 notification of major interests in shares 1. Identity of the issuer or the underlying issuer of existing shares to whichvoting rights are attached: Immunodiagnostic Systems Holdings PLC 2. Reason for the notification Transitional disclosure required following implementation of DTR rules 3. Full name of person(s) subject to the notification obligation: New Star Asset Management Limited 4. Full name of shareholder(s) (if different from 3): N/A 5. Date of the transaction (and date on which the threshold is crossed orreached if different): N/A 6. Date on which issuer notified: 15 March 2007 7. Threshold(s) that is/are crossed or reached: Over 5% 8. Notified details: A: Voting rights attached to sharesClass/type of Situation previous to Resulting situation after the triggering transactionshares Triggering transaction Notification required under DTR transitional provision 7if possible usingISIN CODE Number of Number of Number of Number of voting rights % of voting rights Shares Voting shares Rights Direct Direct Indirect Direct Indirect Ordinary shares N/A N/A N/A N/A 1,535,000 11.50 B: Financial InstrumentsResulting situation after the triggering transaction Type of financial Expiration date Exercise/ Number of voting % of voting rightsinstrument Conversion Period/ rights that may be Date acquired if the instrument is exercised/ converted N/A N/A N/A N/A N/A Total (A+B)Number of voting rights % of voting rights 1,535,000 11.50 9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: N/A 10. Name of the Proxy holder: N/A 11. Number of voting rights proxy holder will cease to hold: N/A 12. Date on which proxy holder will cease to hold voting rights: N/A 13. Additional information: N/A 14. Contact name: N/A 15. Contact telephone number: N/A This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
14th Apr 20057:01 amRNSResearch Agreement
21st Feb 200510:08 amRNSAcquisition
4th Feb 20054:30 pmRNSExercise of Options
18th Jan 20053:20 pmRNSExercise of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.